These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23640029)

  • 1. A new program for highly reproducible automatic evaluation of the substantia nigra from transcranial sonographic images.
    Blahuta J; Soukup T; Jelinkova M; Bartova P; Cermak P; Herzig R; Skoloudik D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Dec; 158(4):621-7. PubMed ID: 23640029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reliability of transcranial duplex scanning in parkinsonian patients: comparison of different observers and ultrasound systems.
    Vlaar A; Tromp SC; Weber WE; Hustinx RM; Mess WH
    Ultraschall Med; 2011 Jan; 32 Suppl 1():S83-8. PubMed ID: 20094977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease.
    van de Loo S; Walter U; Behnke S; Hagenah J; Lorenz M; Sitzer M; Hilker R; Berg D
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1087-92. PubMed ID: 20543186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility of sonographic measurement of the substantia nigra.
    Skoloudík D; Fadrná T; Bártová P; Langová K; Ressner P; Zapletalová O; Hlustík P; Herzig R; Kannovský P
    Ultrasound Med Biol; 2007 Sep; 33(9):1347-52. PubMed ID: 17544567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study).
    Prati P; Bignamini A; Coppo L; Naldi A; Comi C; Cantello R; Gusmaroli G; Walter U
    J Neural Transm (Vienna); 2017 Jul; 124(7):869-879. PubMed ID: 28451942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.
    Li DH; Zhang LY; Hu YY; Jiang XF; Zhou HY; Yang Q; Kang WY; Liu J; Chen SD
    Parkinsonism Relat Disord; 2015 Aug; 21(8):923-8. PubMed ID: 26066091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Performance of Transcranial Sonography for Evaluating Substantia Nigra Hyper-echogenicity in Patients with Parkinson's Disease.
    Xu R; Chen G; Mao Z; Gao H; Deng Y; Tao A
    Ultrasound Med Biol; 2020 May; 46(5):1208-1215. PubMed ID: 32102740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperechogenicity of the substantia nigra in Parkinson's disease.
    Ressner P; Skoloudík D; Hlustík P; Kanovský P
    J Neuroimaging; 2007 Apr; 17(2):164-7. PubMed ID: 17441838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated segmentation of transcranial sonographic images in the diagnostics of Parkinson's disease.
    Sakalauskas A; Lukoševičius A; Laučkaitė K; Jegelevičius D; Rutkauskas S
    Ultrasonics; 2013 Jan; 53(1):111-21. PubMed ID: 22578750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcranial sonography of the substantia nigra: digital image analysis.
    Skoloudík D; Jelínková M; Blahuta J; Cermák P; Soukup T; Bártová P; Langová K; Herzig R
    AJNR Am J Neuroradiol; 2014 Dec; 35(12):2273-8. PubMed ID: 25059698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcranial sonographic findings may predict prognosis of gastroprokinetic drug-induced parkinsonism.
    Oh YS; Kwon DY; Kim JS; Park MH; Berg D
    Parkinsonism Relat Disord; 2018 Jan; 46():36-40. PubMed ID: 29111425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Age on Substantia Nigra Hyper-echogenicity in Parkinson's Disease Patients and Healthy Controls.
    Toomsoo T; Liepelt-Scarfone I; Berg D; Kerner R; Pool AH; Kadastik-Eerme L; Rubanovits I; Asser T; Taba P
    Ultrasound Med Biol; 2019 Jan; 45(1):122-128. PubMed ID: 30482710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
    Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
    Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substantia nigra echogenicity correlated with clinical features of Parkinson's disease.
    Zhou HY; Sun Q; Tan YY; Hu YY; Zhan WW; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
    Parkinsonism Relat Disord; 2016 Mar; 24():28-33. PubMed ID: 26842545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prediction of pouch of Douglas obliteration using offline analysis of the transvaginal ultrasound 'sliding sign' technique: inter- and intra-observer reproducibility.
    Reid S; Lu C; Casikar I; Mein B; Magotti R; Ludlow J; Benzie R; Condous G
    Hum Reprod; 2013 May; 28(5):1237-46. PubMed ID: 23482338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between substantia nigra features detected by sonography and Parkinson disease symptoms.
    Bártová P; Skoloudík D; Ressner P; Langová K; Herzig R; Kanovsky P
    J Ultrasound Med; 2010 Jan; 29(1):37-42. PubMed ID: 20040773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease.
    Huang YW; Jeng JS; Tsai CF; Chen LL; Wu RM
    Mov Disord; 2007 Mar; 22(4):550-5. PubMed ID: 17260344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between a handheld ultrasound device and a traditional ultrasound for performing transcranial sonography in patients with Parkinson's disease.
    Paes MAS; Nicaretta DH; Alvarenga RMP; Rosso ALZ; Brisson RT; Fernandes RCL
    Brain Behav; 2023 Feb; 13(2):e2891. PubMed ID: 36706022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson's disease: a Chinese population-based study.
    Li T; Shi J; Qin B; Fan D; Liu N; Ni J; Zhang T; Zhou H; Xu X; Wei M; Zhang X; Wang X; Liu J; Wang Y; Tian J
    Neurol Sci; 2020 Mar; 41(3):661-667. PubMed ID: 31754876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
    Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
    Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.